Current standard adjuvant therapies for premenopausal women with early breast cancer include ovarian ablation by surgery or irradiation, chemotherapy and tamoxifen. The value of ovarian ablation in ...
AstraZeneca and Biovail have entered into an agreement in which Biovail’s specialty sales force will promote AstraZeneca’s Zoladex (goserelin acetate implant) to obstetricians and gynecologists for ...
AstraZeneca today announced plans to invest £120 million ($190 million) in a new facility at its global manufacturing site in Macclesfield, UK, to continue production of Zoladex, an injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results